Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Pregabalin
Pregabalin is an anticonvulsant and anti-anxiety medication used to treat a range of conditions, including epilepsy, nerve pain, fibromyalgia, and generalized anxiety disorder [1]. The medication works by modulating the activity of calcium channels in the brain to reduce the release of neurotransmitters associated with pain, anxiety, and seizures [2]. Research has shown that pregabalin is effective in managing symptoms of restless legs syndrome, neuropathic pain, and postherpetic neuralgia [3]. However, side effects such as dizziness, drowsiness, and weight gain can occur in some patients [4]. Pregabalin is marketed under the brand name Lyrica, among others, and its availability in various forms, including capsules, oral solution, and powder for oral solution [5]. According to DrugPatentWatch.com, the patent for Lyrica expired in 2018, allowing generic versions of the medication to become available [6]. Sources: [1] https://pubmed.ncbi.nlm.nih.gov/15713970/ [2] https://www.pharmgkb.org/pathway/PA179000047 [3] https://pubmed.ncbi.nlm.nih.gov/16314515/ [4] https://www.drugs.com/side-effects/lyrica.html [5] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021366Orig1s032bl.pdf [6] https://www.drugpatentwatch.com/drug/lyrica-oral-tablet
Other Questions About Pregabalin :